This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Abstract
A de novo IL2/IL15 mimic has improved antitumor activity and reduced toxicity compared with native IL2.
- ©2019 American Association for Cancer Research.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
March 2019
Volume 9, Issue 3
Volume 9, Issue 3
De Novo Cytokine Mimics Have Improved Therapeutic Properties
Jump to section
Advertisement